Merck KGaA (ETR:MRK)
125.90
+0.75 (0.60%)
May 13, 2025, 1:04 PM CET
Merck KGaA Revenue
In the year 2024, Merck KGaA had annual revenue of 21.16B EUR with 0.78% growth. Merck KGaA had revenue of 5.42B in the quarter ending December 31, 2024, with 3.69% growth.
Revenue
21.16B
Revenue Growth
+0.78%
P/S Ratio
2.57
Revenue / Employee
358.45K
Employees
59,020
Market Cap
54.41B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 21.16B | 163.00M | 0.78% |
Dec 31, 2023 | 20.99B | -1.24B | -5.57% |
Dec 31, 2022 | 22.23B | 2.55B | 12.93% |
Dec 31, 2021 | 19.69B | 2.15B | 12.28% |
Dec 31, 2020 | 17.53B | 1.38B | 8.56% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.14B |
Fresenius SE & Co. KGaA | 22.13B |
Bayer Aktiengesellschaft | 46.61B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.44B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.33B |
SCHOTT Pharma AG & Co. KGaA | 954.68M |
Merck KGaA News
- 13 days ago - SpringWorks: Acquired By Merck KGaA Based On Rare Tumor Targeting Drugs Like OGSIVEO - Seeking Alpha
- 14 days ago - SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating SpringWorks Therapeutics, Inc. Buyout - Wallstreet:Online
- 15 days ago - SWTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of SpringWorks Therapeutics, Inc. Is Fair to Shareholders - Wallstreet:Online
- 15 days ago - Germany's Merck Agrees to Buy US Biotech SpringWorks Therapeutics for Almost $4B - Investopedia
- 15 days ago - Wall Street Breakfast Podcast: Huawei Preps AI Chip To Challenge Nvidia: Report - Seeking Alpha
- 15 days ago - Santé : Merck KGaA acquiert l'américain SpringWorks Therapeutics pour 3,4 milliards de dollars - Le Figaro
- 15 days ago - Merck KGaA (MKGAF) to Acquire SpringWorks Therapeutics for $3.9 Billion - GuruFocus
- 15 days ago - Merck KGaA to Acquire SpringWorks Therapeutics for $3.9 Billion | SWTX stock news - GuruFocus